Skip to Main Content

Author Details

Jared Carlson-Stevermer
Synthego Corporation
2015
19
12
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
35027731BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.Nat Cell Biol2022
35839775Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.Cell Rep2022
33333024Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.Cell2021
33501440BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.bioRxiv2021
34816261Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2.bioRxiv2021
34320401Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.Cell Rep2021
32995787Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses.bioRxiv2020
31699335Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics.Biophys J2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33028827CRISPRoff enables spatio-temporal control of CRISPR editing.Nat Commun2020
33293555Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases.Nat Commun2020
30604771CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage.Nat Commun2019
31086832Increasing the precision of gene editing <i>in vitro</i>, <i>ex vivo,</i> and <i>in vivo</i>.Curr Opin Biomed Eng2018
29167458Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing.Nat Commun2017
28353269Genome Editing in Human Pluripotent Stem Cells.Methods Mol Biol2017
26771356High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells.Stem Cell Reports2016
26747759High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.Acta Biomater2016
25964348A tortoise-hare pattern seen in adapting structured and unstructured populations suggests a rugged fitness landscape in bacteria.Proc Natl Acad Sci U S A2015
  • 1 - 19 of 19

Recommended Authors

Wyss Institute for Biologically Inspired Engineering, Harvard University
Career Start Year 2018
Number of shared co-authors 0
Sean N. Parker Center for Allergy and Asthma Research at Stanford University
Career Start Year 2016
Number of shared co-authors 3
McGovern Institute for Brain Research at MIT Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 2013
Number of shared co-authors 0
Brigham & Women's Hospital and Harvard Medical School
Career Start Year 2013
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 2012
Number of shared co-authors 7
College of Resources and Environment, Southwest University
Career Start Year 2012
Number of shared co-authors 0
CSIR-Institute of Genomics & Integrative Biology
Career Start Year 2012
Number of shared co-authors 1
McGovern Institute for Brain Research at MIT Massachusetts Institute of Technology
Career Start Year 2012
Number of shared co-authors 1
Genome Institute of Singapore
Career Start Year 2011
Number of shared co-authors 0
GC Therapeutics Inc.
Career Start Year 2011
Number of shared co-authors 0
University of California berkeley
Career Start Year 2009
Number of shared co-authors 8
Stanford University
Career Start Year 2008
Number of shared co-authors 7
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
University of Minnesota
Career Start Year 2007
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2007
Number of shared co-authors 0
Arc Institute
Career Start Year 2007
Number of shared co-authors 10
Center for Genomic Medicine, Massachusetts General Hospital
Career Start Year 2007
Number of shared co-authors 2
Tokyo Metropolitan Institute of Medical Science, Japan Gladstone Institutes
Career Start Year 2006
Number of shared co-authors 5
St. Jude Children's Research Hospital.
Career Start Year 2006
Number of shared co-authors 1
The University of Hong Kong
Career Start Year 2005
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2005
Number of shared co-authors 0
Pittsburgh Liver Research Center, University of Pittsburgh
Career Start Year 2005
Number of shared co-authors 0
University of California San Diego
Career Start Year 2004
Number of shared co-authors 3
Massachusetts Institute of Technology, USA Broad Institute
Career Start Year 2004
Number of shared co-authors 0
Chinese Academy of Sciences
Career Start Year 2003
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 2
University Hospital Carl Gustav Carus, Technische Universitat (TU) Dresden
Career Start Year 1989
Number of shared co-authors 2
Stanford University
Career Start Year 1984
Number of shared co-authors 0
Exercise Medicine Research Institute, Edith Cowan University
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Synthego Corporation
Co-authored papers 8
Synthego Corporation
Co-authored papers 8
University of California San Francisco
Co-authored papers 6
Gladstone Institute of Virology
Co-authored papers 5
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 4
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
University of Michigan Medical School ann arbor
Co-authored papers 4
Gladstone Institutes
Co-authored papers 4
University of Alabama at Birmingham
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
University of California at San Francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Gladstone Institute of Virology
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
J. David Gladstone Institutes
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 2
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 2
Gladstone Institutes
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
J. David Gladstone Institutes
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Gladstone Institutes
Co-authored papers 2
Gladstone Institutes
Co-authored papers 2